Sonorous Neurovascular Receives FDA Breakthrough Device Designation for BosSTENT™

LAKE FOREST, Calif., Feb. 5, 2026 /PRNewswire/ -- Sonorous Neurovascular, a pioneering medical device company dedicated to advancing neurovascular therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the BosSTENT™ device.  Read more